REC Recordati Industria Chimica e Farmaceutica S.p.A.

57.86USD52.75 EUR · BIT-0.09%Mkt Cap: 12.04B USDP/E: 21.02

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, P…

Institutional holders12 on file

Key Statistics

Company
Market Cap12.04B USD
Enterprise Value13.83B USD
Revenue (TTM)3.03B USD
Gross Profit1.96B USD
Net Income (TTM)486.57M USD
Revenue/Share14.82 USD
Last Price57.86 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees4.7K
CountryIT
SectorHealthcare
IndustryDrug Manufacturers - General
ISINIT0003828271
Valuation
P/E (Trailing)21.02
P/E (Forward)13.92
PEG1.10
EV/EBITDA11.57
EV/Revenue4.56
P/S3.97
P/B4.66
EPS (TTM)2.75 USD
EPS (Forward)4.15 USD
52W Range
48.0090% of range58.90
52W High58.90 USD
52W Low48.00 USD
Profitability
Gross Margin68.27%
Oper. Margin32.56%
EBITDA Margin39.39%
Profit Margin16.94%
ROE23.11%
ROA8.45%
ROIC13.88%
ROCE17.14%
Growth
Revenue Growth9.60%
Earnings Growth24.90%
Cash Flow & Leverage
Operating CF654.68M USD
CapEx (TTM)93.36M USD
FCF Margin18.59%
FCF Yield4.68%
Net Debt1.87B USD
Net Debt/EBITDA1.56
Net Debt/FCF3.32
Balance Sheet
Debt/Equity1.29
Current Ratio1.34
Quick Ratio0.91
Book Value/Sh12.41 USD
Cash/Share2.67 USD
Dividends
Fwd Div Rate1.56 USD
Trail. Div Rate0.78 USD
Div. Yield2.69%
5Y Avg Yield2.49%
Payout Ratio53.37%
Ex-Div DateMay 18, 2026
Pay Date—
Splits
Last Split4:1
Split DateApr 18, 2005
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)62.33 USD
Upside (mean)+7.7%
Target Range56.27 USD – 77.87 USD
56.27+7.7% to mean77.87
# Analysts7
Ownership
Shares Out.208.13M
Float100.70M
Insiders46.82%
Institutions32.17%
Technical
SMA 5057.97 (-0.2%)
SMA 20055.78 (+3.7%)
Beta0.51
S&P 52W Chg12.00%
Avg Vol (30d)511.53K
Avg Vol (10d)790.30K
Technical Indicators
RSI (14)46.9
MACD-0.0382
MACD Signal-0.0059
MACD Hist.-0.0322
BB Upper58.69 USD
BB Middle58.06 USD
BB Lower57.44 USD
BB Width2.15%
ATR (14)0.2467 USD
Vol Ratio (20d)0.98x

About Recordati Industria Chimica e Farmaceutica (BIT: REC)

›

Recordati Industria Chimica e Farmaceutica (BIT: REC) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector, and reports about 4,700 employees.

The shares were at 52.75 EUR on 19 November 2026, up 2.2% over 52 weeks. Its 52-week range is 43.76 EUR to 53.70 EUR: the price is 1.8% below the high and 20.5% above the low.

At a market capitalisation of 10.98B EUR, it trades at 21.0 times trailing earnings and 13.9 times forward earnings. The median trailing P/E of its 19 largest Drug Manufacturers - General peers is 26.0, a discount of 19% for REC. It pays a dividend yielding 2.69% (it pays out 53% of its earnings), against a median of 2.43% among the dividend payers in that peer group.

Recordati Industria Chimica e Farmaceutica reports return on equity of 23.1%, an operating margin of 32.6% and revenue up 9.6% year over year.

Its debt exceeds its cash by 1.70B EUR, a debt-to-equity ratio of 1.29. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Hold; their mean price target of 56.83 EUR is 7.7% above the current price. The next earnings report is expected on 18 March 2027.